耐火性高血症是转移性副甲状腺癌的次要症状,用免疫疗法治疗
Brenda Ta1,2,3, Michael James Bennett1,3,4,5
1Department of Endocrinology and Diabetes, Prince of Wales Hospital, Randwick 2031, Australia.
JCEM case reports
|July 16, 2024
概括
甲状腺癌是一种罕见的癌症,可以导致严重的高血症. 尼沃卢马布的免疫疗法有效地治疗了一名患有晚期副甲状腺癌和耐火性高血症的患者.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 副甲状腺癌 (PC) 是一种罕见的内分泌恶性瘤,导致原发性副甲状腺癌.
- 转移性PC的预后不好,治疗选择有限.
更多相关视频
09:02Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
11.9K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
708
相关概念视频
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
